/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-09-11-14-05-22-574-66e1a3a2fd5f6342208d14c9.jfif)
The implications of the recent Illumina/Grail Judgment Executive Summary In a landmark EU judgment, on 3 September 2024, the Court of...
Cortex - Life Sciences Insights
/Passle/64356addf636e90f3c0b1d4f/SearchServiceImages/2024-01-15-17-17-42-540-65a568b6d73fe9635bbf60a8.jpg)
As 2024 begins, large players in the CGFR sector active in Ireland will need to navigate a new and ambitious regulator governing the...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-07-05-16-06-08-126-62c46170f636e91b5cb10445.jpg)
On 29 June 2022, Ireland enacted major reforms to its Competition Act. These changes could have a significant impact across most sectors...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/5ed622ef8cb62a041c7fddf8/2021-06-03-10-15-34-987-60b8abc6400fb30bd8bd773d.jpg)
Back in April 2017, The Times ran a story detailing how a drug giant had a “secret plan” to destroy a cancer medicine unless large price...
On 25 November 2020, the European Commission published its Pharmaceutical Strategy for Europe (Strategy). The Strategy is relevant for...
What are commitments? The recent effort by the Commission to settle the Aspen case suggests that commitment decisions are the preferred...
